|
" Arterial wall disease and stroke prevention : "
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
714893
|
| Doc. No
|
:
|
b537045
|
| Title & Author
|
:
|
Arterial wall disease and stroke prevention : : Sanofi-Synthelabo and Bristol-Myers Squibb Plenary Session to the 9th European Stroke Conference, Vienna, Austria, May 24-27, 2000.
|
| Publication Statement
|
:
|
2000
|
| Series Statement
|
:
|
Cerebrovascular diseases (Basel. Print), 10: suppl. 5.
|
| Page. NO
|
:
|
48 s.
|
| ISBN
|
:
|
380557150X
|
|
|
:
|
: 9783805571500
|
| Contents
|
:
|
European Stroke Initiative recommendations for stroke management; recent infection as a risk factor for intracerebral and subarachnoid hemorrhages; the thrombomodulin gene mutation G127A (Ala25Thr) and cerebrovascular disease; early 99mTc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery; epileptic seizures attributed to cerebral hyperperfusion after percutaneous transluminal angioplasty and stenting of the internal carotid artery; swallowing disorders following acute stroke - prevalence and diagnostic accuracy; risk factors for lacunar infarcts; delayed intrahemispheric remote hypometabolism; cerebral microembolus detection in an unselected acute ischemic stroke population; chronological changes in cerebral air embolism that occurred during continuous drainage of infected lung bullae; stroke as the first manifestation of calcific aortic stenosis; a case of diffuse cerebral vasospasm - possibly ergotamine-associated?
|
| Subject
|
:
|
Arteries -- pathology.
|
| Subject
|
:
|
Arteriosclerosis.
|
| Subject
|
:
|
Stroke -- prevention control.
|
| |